Exscientia (EXAI) News Today $4.90 +0.02 (+0.41%) (As of 09/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 4 at 1:27 PM | marketbeat.comExscientia (NASDAQ:EXAI) Shares Up 4.5%Exscientia (NASDAQ:EXAI) Stock Price Up 4.5%September 3, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Sees Unusually-High Trading VolumeExscientia (NASDAQ:EXAI) Sees Strong Trading VolumeSeptember 2, 2024 | marketbeat.comShort Interest in Exscientia plc (NASDAQ:EXAI) Grows By 15.7%Exscientia plc (NASDAQ:EXAI - Get Free Report) was the recipient of a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 3,690,000 shares, a growth of 15.7% from the July 31st total of 3,190,000 shares. Approximately 3.5% of the shares of the stock are short sold. Based on an average trading volume of 593,200 shares, the short-interest ratio is currently 6.2 days.August 31, 2024 | msn.comExscientia Plc (EXAI): A Penny Stock That Will Make You a MillionaireAugust 30, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Shares Gap Up to $5.66Exscientia (NASDAQ:EXAI) Shares Gap Up to $5.66August 29, 2024 | finance.yahoo.comExscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceAugust 27, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Stock Price Down 4.2%Exscientia (NASDAQ:EXAI) Stock Price Down 4.2%August 25, 2024 | marketbeat.comExscientia plc (NASDAQ:EXAI) Stake Cut by Baillie Gifford & Co.Baillie Gifford & Co. decreased its holdings in shares of Exscientia plc (NASDAQ:EXAI - Free Report) by 3.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,397,618 shares of the company's stock after selAugust 20, 2024 | marketbeat.comExscientia plc (NASDAQ:EXAI) Short Interest Down 12.4% in JulyExscientia plc (NASDAQ:EXAI - Get Free Report) was the target of a significant drop in short interest during the month of July. As of July 31st, there was short interest totalling 3,190,000 shares, a drop of 12.4% from the July 15th total of 3,640,000 shares. Based on an average daily volume of 557,400 shares, the short-interest ratio is presently 5.7 days. Currently, 2.7% of the company's shares are sold short.August 19, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Stock Price Down 2.8%Exscientia (NASDAQ:EXAI) Stock Price Down 2.8%August 18, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Issues Quarterly Earnings ResultsExscientia (NASDAQ:EXAI - Get Free Report) announced its earnings results on Thursday. The company reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of ($0.31) by ($0.05). Exscientia had a negative net margin of 666.80% and a negative return on equity of 34.59%. The business had revenue of $5.60 million during the quarter.August 16, 2024 | finance.yahoo.comNews Flash: 4 Analysts Think Exscientia plc (NASDAQ:EXAI) Earnings Are Under ThreatAugust 16, 2024 | markets.businessinsider.comMaintaining Hold Rating on Exscientia Plc Amid Anticipated Developments and Clinical MilestonesAugust 15, 2024 | theglobeandmail.comHow A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market UpdatesAugust 15, 2024 | finance.yahoo.comExscientia Business Update for Second Quarter and First Half 2024August 14, 2024 | msn.comBarclays Downgrades Exscientia plc - Depositary Receipt () (EXAI)August 13, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Receives Equal Weight Rating from BarclaysBarclays reaffirmed an "equal weight" rating and set a $5.00 price objective on shares of Exscientia in a research note on Tuesday.August 13, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Stock Price Down 3.1%Exscientia (NASDAQ:EXAI) Trading Down 3.1%August 12, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Shares Gap Down to $5.05Exscientia (NASDAQ:EXAI) Shares Gap Down to $5.05August 9, 2024 | msn.comTD Cowen Downgrades Exscientia plc - Depositary Receipt () (EXAI)August 9, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Stock Rating Reaffirmed by TD CowenTD Cowen reaffirmed a "hold" rating on shares of Exscientia in a research note on Friday.August 9, 2024 | uk.finance.yahoo.comConsumer exhibiting 'selectivity' while spending on travelAugust 9, 2024 | sg.finance.yahoo.com(078100.TW)August 9, 2024 | finance.yahoo.comRecursion and Exscientia merge to form drug discovery companyAugust 8, 2024 | seekingalpha.comRecursion's Acquisition Of Exscientia Makes Sense On Some Levels, Not OthersAugust 6, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Trading 6.3% Higher Exscientia (NASDAQ:EXAI) Stock Price Up 6.3%August 5, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Reaches New 52-Week Low at $3.83Exscientia (NASDAQ:EXAI) Reaches New 1-Year Low at $3.83August 2, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Shares Gap Up to $4.60Exscientia (NASDAQ:EXAI) Shares Gap Up to $4.60July 31, 2024 | msn.comWhy Do Hedge Funds Think That Exscientia plc (EXAI) Will Skyrocket?July 30, 2024 | markets.businessinsider.comMorgan Stanley Keeps Their Hold Rating on Exscientia Plc (EXAI)July 18, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Stock Price Down 5.2%Exscientia (NASDAQ:EXAI) Shares Down 5.2%July 15, 2024 | marketbeat.comShort Interest in Exscientia plc (NASDAQ:EXAI) Declines By 12.6%Exscientia plc (NASDAQ:EXAI - Get Free Report) was the recipient of a significant drop in short interest in the month of June. As of June 30th, there was short interest totalling 3,750,000 shares, a drop of 12.6% from the June 15th total of 4,290,000 shares. Based on an average daily volume of 506,100 shares, the days-to-cover ratio is presently 7.4 days. Currently, 3.2% of the shares of the company are sold short.July 11, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Stock Price Down 1.9%Exscientia (NASDAQ:EXAI) Shares Down 1.9%July 9, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Stock Price Up 4.7%Exscientia (NASDAQ:EXAI) Stock Price Up 4.7%July 9, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Receives New Coverage from Analysts at TD CowenTD Cowen started coverage on Exscientia in a report on Tuesday. They set a "buy" rating for the company.July 8, 2024 | investorplace.com3 Small-Cap Stocks With Explosive 2X Growth PotentialJuly 3, 2024 | marketbeat.comExscientia (NASDAQ:EXAI) Stock Price Up 6.5%Exscientia (NASDAQ:EXAI) Shares Up 6.5%June 25, 2024 | businesswire.comEXAI Investors Have Opportunity to Lead Exscientia plc Securities Fraud Lawsuit with the Schall Law FirmJune 25, 2024 | prnewswire.comEXAI LAWSUIT ALERT: The Gross Law Firm Notifies Exscientia plc Investors of a Class Action Lawsuit and Upcoming DeadlineJune 25, 2024 | prnewswire.comEXAI Today Is The Last Day that Investors can Lead Exscientia plc Fraud LawsuitJune 24, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exscientia p.l.c.June 24, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Exscientia p.l.c. of Class Action Lawsuit and Upcoming Deadlines - EXAIJune 24, 2024 | globenewswire.comEXAI FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Exscientia p.l.c. Investors to Secure Counsel Before Important June 25 Deadline in Securities Class Action – EXAIJune 24, 2024 | prnewswire.comEXAI DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Exscientia p.l.c. Investors to Secure Counsel Before Important June 25 Deadline in Securities Class Action - EXAIJune 24, 2024 | businesswire.comEXAI Investors Have Opportunity to Lead Exscientia plc Securities Fraud Lawsuit with the Schall Law FirmJune 22, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Exscientia p.l.c. of Class Action Lawsuit and Upcoming Deadlines – EXAIJune 21, 2024 | globenewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ExscientiaJune 21, 2024 | globenewswire.comLowey Dannenberg Notifies Exscientia p.l.c. (“Exscientia” or the “Company”) (NASDAQ: EXAI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the FirmJune 21, 2024 | globenewswire.comEXAI Investors Have Opportunity to Lead Exscientia plc Securities Fraud Lawsuit with the Schall Law FirmJune 21, 2024 | prnewswire.comExscientia plc Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 25, 2024 to Discuss Your Rights - EXAI Get Exscientia News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAI and its competitors with MarketBeat's FREE daily newsletter. Email Address China Stockpiling Gold “Like No Tomorrow” (Ad)For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… . Click here now to get your free 'De-Dollarization' Guide. EXAI Media Mentions By Week EXAI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAI News Sentiment▼0.790.55▲Average Medical News Sentiment EXAI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAI Articles This Week▼35▲EXAI Articles Average Week Get Exscientia News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AbCellera Biologics News Today Relay Therapeutics News Today Schrödinger News Today ImmunityBio News Today Catalyst Pharmaceuticals News Today Janux Therapeutics News Today Bausch Health Companies News Today Amphastar Pharmaceuticals News Today Vericel News Today Twist Bioscience News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAI) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exscientia plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Exscientia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
